Related Experiment Video
Updated: Jul 4, 2026

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Alternative forms of tobacco use
J J Prignot1, A J Sasco, E Poulet
1University of Louvain, Louvain, Belgium. jacques.prignot@uclouvain.be
Alternative tobacco products like narghile and bidis pose significant health risks, often exceeding those of cigarettes. Safer nicotine alternatives require further evaluation before use as cigarette substitutes.
Area of Science:
- Public Health
- Tobacco Control
- Toxicology
Background:
- Review of scientific literature on non-cigarette tobacco products.
- Examination of prevalence, trends, and health effects.
- Analysis of regulatory and preventive measures.
Purpose of the Study:
- To synthesize current knowledge on alternative tobacco products.
- To assess the health risks associated with these products.
- To inform regulatory and preventive strategies.
Main Methods:
- Literature review of scientific publications.
- Analysis of prevalence data and trends.
- Evaluation of health effects and regulatory landscape.
Main Results:
- Narghile, bidis, and oral tobacco are spreading globally with health risks comparable to or exceeding cigarette smoking.
- Potentially Reduced Exposure Products (PREPs) like snus have variable and not fully known pathogenic potential, greater than pure nicotine.
- These alternative products are not safe and require tailored regulatory and preventive measures.
Conclusions:
- No tobacco product is safe; all carry health risks.
- Alternative tobacco products necessitate adapted regulatory and preventive measures.
- International frameworks like the WHO FCTC are crucial for tobacco control.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Stress Prevention and Stress Management Techniques IV
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...

